Skip to Content

UK Edition. Click here for US version.

ALMUS PEPTI-CALM SUSPENSION BISMUTH SUBSALICYLATE 525.6MG/30ML

Active substance(s): BISMUTH SUBSALICYLATE

View full screen / Print PDF » Download PDF ⇩
Transcript
Page 1
Label-leaflet for Almus Pepti-Calm Suspension Bismuth Subsalicylate 525.6mg/30ml
(Yellow Card October 2014)
[Base Label]

Almus Pepti-Calm Suspension
Bismuth Subsalicylate 525.6mg / 30ml
Relief of nausea,
upset stomach,
diarrhoea, indigestion
and heartburn
[P] Pharmacy Medicine

300ml e
Read all of this label for full instructions.

Before you take this medicine
X Do not take:
 If you are allergic to any of the ingredients in the medicine, aspirin or any other nonsteroidal anti-inflammatory medicines.
 If you are taking medicines containing aspirin
 If you have kidney problems or gout
 If you have intolerance to some sugars unless your doctor tells you to (this medicine
contains maltitol liquid)
 If you are pregnant or breastfeeding

! Talk to your pharmacist or doctor:



If you are on a low salt (sodium) diet (each 30 ml contains 63 mg of sodium)
If you take other medicines – warfarin or other blood thinners, tablets for diabetes (e.g.
chlorpropamide, glibenclamide), medicines to treat gout (e.g. probenecid)
There is a possible association between salicylates and Reye’s syndrome when given to
children. Reye’s syndrome is a very rare disease, which can be fatal. For this reason
salicylates should not be given to children under 16 years, unless on the advice of a doctor.
This medicines contains maltitol liquid which may have a mild laxative effect. Each 30 ml
contains 8 g of maltitol. This provides 18 kcal per 30 ml.
Glycerol may cause headache, stomach upset and diarrhoea. The colour (E122) in this
medicine may cause allergic reactions.

Page 2
Label-leaflet for Almus Pepti-Calm Suspension Bismuth Subsalicylate 525.6mg/30ml
(Yellow Card October 2014)

 How to take this medicine
Check the seal is not broken before first use. If it is, do not take the medicine.
Shake the bottle.
Use the measuring cup provided.
Adults and children of 16 years and over: Swallow 30 ml every 30 to 60 minutes if you
need to, up to a maximum of 8 times in 24 hours.
Do not give to children under 16 years.
Do not exceed the stated dose.
If symptoms are severe, talk to your pharmacist or doctor.
If symptoms do not go away within 2 days, talk to your pharmacist or doctor.
Do not store above 25C.

! If you take too much: Talk to a doctor straight away.

Possible side effects
Most people will not have problems, but some may get some of these:
 Feeling sick and being sick
 Darkening or blackening of the stools and tongue

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
possible side effects not listed on this label. You can also report side effects directly via the
Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can
help provide more information on the safety of this medicine.

How to store this medicine
Do not store above 25°C.
Keep all medicines out of the sight and reach of children.
Use by the date on the label edge.

What is in this medicine
Active ingredient: Each 30ml ml of oral suspension contains Bismuth Subsalicylate 525.6
mg
Also contains: purified wate, glycerol, maltitol liquid (E965), microcrystalline cellulose,
xanthan gum, citric acid monohydrate, carmellose sodium, sodium citrate, sodium benzoate
(211), carmoisine (E122), root beer flavour (containing propylene glycol).
PL 00014/0615
[P]
Text prepared 10/14
MA holder: BCM, Nottingham, NG2 3AA
Manufacturer: BCM Ltd., Nottingham, NG2 3AA
If you need more advice ask a pharmacist
Almus® is a registered trademark

Page 3
Label-leaflet for Almus Pepti-Calm Suspension Bismuth Subsalicylate 525.6mg/30ml
(Yellow Card October 2014)
Item code:
Lot:
Use By:
Component code

BRAILLE NAME (on label)
Almus Pepti-Calm Suspension Bismuth Subsalicylate #525.6mg/#30ml

ALMUS ARTWORK STATUS BOX
Product Name: Almus Pepti-Calm Suspension Bismuth Subsalicylate 525.6mg/30ml
Product Licence Number: PL00014/0615
Reason for change: MHRA Yellow Card Warning, October 2014

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide